pBK-EQR-BE3 Citations (1)

Originally described in: Increasing the genome-targeting scope and precision of base editing with engineered Cas9-cytidine deaminase fusions.
Kim YB, Komor AC, Levy JM, Packer MS, Zhao KT, Liu DR Nat Biotechnol. 2017 Feb 13. doi: 10.1038/nbt.3803. PubMed Journal

---

Articles Citing pBK-EQR-BE3

Showing 1 to 1 of 1 entries

Show 102550100All entries

Search table:

• Previous
• 1
• Next

Articles
Base editing strategy for insertion of the A673T mutation in the APP gene to prevent the development of AD in vitro. Guyon A, Rousseau J, Begin FG, Bertin T, Lamothe G, Tremblay JP. Mol Ther Nucleic Acids. 2021 Mar 1;24:253-263. doi: 10.1016/j.omtn.2021.02.032. eCollection 2021 Jun 4. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.